Cholesterol DrugsVideo
Categories
- Allergy
- Alzheimer's Disease
- Arthritis
- Asthma
- Breast Cancer
- Cardio Health
- Cholesterol
- Cold and Flu
- Colon Cancer
- Diabetes
- Dieting
- Epilepsy
- Hair Loss
- Headache
- Heartburn
- HIV & AIDS
- Kidney Health
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Sclerosis
- Men's Health
- Mental Health
- Nutrition
- Osteoporosis
- Parkinson's Disease
- Prostate Health
- Skin Health
- Sleep Disorders
- Women's Health
- General
Drug Combo May Relieve MS Symptoms
Posted on 04/30/2009, 12:00
By -- Robert Preidt
Adding steroid to multiple sclerosis treatment shows promise in study
THURSDAY, April 30 (HealthDay News) -- Using a steroid drug in combination with a multiple sclerosis (MS) drug may give patients more relief from symptoms than using the MS drug alone, suggests a new study.
In the study, which included 341 people with relapsing-remitting MS, some patients were randomly selected to receive the steroid drug methylprednisolone in three doses over three days once a month, in addition to regular treatment with the MS drug interferon beta-1a. Others received the interferon drug and a placebo.
During the three-year study, the patients were assessed every three months. Those who took the steroid/interferon drug combination had 38 percent fewer relapses (episodes when the disease is active) than those who took the placebo and interferon, the study found. The patients in the steroid/interferon group also showed slight improvement on a test of MS disability, while those in the placebo/interferon group showed a slight decline.
The Biogen Idec-supported study also found that MS-related brain lesions stayed the same size or shrank in the steroid/interferon group but grew larger in the placebo/interferon group. The findings were presented this week at the annual meeting of the American Academy of Neurology, in Seattle.
"These results indicate that these two drugs may have a synergy when taken together and provide a more beneficial effect on the disease activity," study author Dr. Mads Ravnborg, of the Danish Multiple Sclerosis Research Center at Copenhagen University Hospital in Denmark, said in an American Academy of Neurology news release. "This is a promising finding, as the benefit from interferon is only moderate, and not everyone responds fully to the treatment, so anything we can do to boost those results is positive."
More information
The National Multiple Sclerosis Society has more about MS treatments.
SOURCE: American Academy of Neurology, news release, April 30, 2009
Copyright © 2009 ScoutNews, LLC. All rights reserved.
More news in Multiple Sclerosis...
BigHealthTree.com Disclaimer
Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.
Babies in the Womb May Already Be Learning Language
Some Doctors Prescribe Antibiotics Because Parents Want Them
What Kids Wear Could Determine How Much Exercise They Get
Few College Students Have Received the H1N1 Vaccine
Night Lights Could Lead to Depression
Cervarix Has Been Approved by the FDA
The FDA Is Studying the Effects of Lasik Surgery
Painkillers Can Dull the Effects of Childhood Vaccines
Childbirth May Becoming More Complicated
Botox Sponges Might Help Nose Allergies
The FDA Advises on How to Properly Dispose of Medicine
A French Study Shows Cell Phones Do Not Affect Humans
MRIs May Lead to More Back Surgery
Your More Likely to Wash Your Hands If Someone's Watching

Comments (0):
Be the first to comment on this article.
Post a comment